EDWARDS LIFESCIENCES CORPORATION Funds and ETFs Edwards Lifesciences Corporation
Equities
EW
US28176E1082
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 88.14 USD | +0.52% |
|
+1.44% | +15.59% |
ETFs positioned on Edwards Lifesciences Corporation
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 114 M€ | +4.36% | - | |
| 0.01% | 163 M€ | +0.31% | - | |
| 0.01% | 32 M€ | +4.30% | - | |
| 5.02% | 132 M€ | +8.76% | - |
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Calendar
2024-07-24
- Q2 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
88.14
USD
Average target price
96.31
USD
Spread / Average Target
+9.27%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +15.59% | 53.11B | |
| +9.48% | 222B | |
| +13.72% | 195B | |
| +23.79% | 148B | |
| +33.39% | 113B | |
| +4.75% | 66.45B | |
| +3.16% | 50.03B | |
| -4.35% | 38.8B | |
| -1.27% | 34.85B | |
| +22.61% | 30.98B |
- Stock Market
- Equities
- EW Stock
- Funds and ETFs Edwards Lifesciences Corporation
